This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Zeppetella, G. Search for Related Content PubMed PubMed Citation Articles by Zeppetella, G. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Breathing Problems Lung Cancer Palliative Care Hazardous Substances DB MORPHINE Social Bookmarking                         What's this?

Nebulized morphine in the palliation of dyspnoea

St Joseph's Hospice, Mare Street, Hackney, London

Seventeen terminally ill cancer patients with primary or secondary intra- thoracic malignancy complaining of breathlessness were treated with nebulized morphine in doses of 20 mg 4-hourly for 48 h. The effect on dyspnoea was evaluated using the Dyspnoea Assessment Questionnaire. Most patients felt less dyspnoeic after 24 h; the effect was maintained, but not improved upon, after 48 h.

Key Words: administration • inhalation • dyspnoea • lung neoplasms • morphine • palliative treatment

Palliative Medicine, Vol. 11, No. 4, 267-275 (1997)
DOI: 10.1177/026921639701100402


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P. W. Keeley, E. T. Waterhouse, and S. I.R. Noble The evidence base of palliative medicine: is inpatient palliative medicine evidence-based? Palliative Medicine, October 1, 2007; 21(7): 623 - 627. [Abstract] [PDF]

				P. A. Kvale, P. A. Selecky, and U. B. S. Prakash Palliative Care in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 368S - 403S. [Abstract] [Full Text] [PDF]

				S. J Brown, S. F Eichner, and J. R Jones Nebulized Morphine for Relief of Dyspnea Due to Chronic Lung Disease Ann. Pharmacother., June 1, 2005; 39(6): 1088 - 1092. [Abstract] [Full Text] [PDF]

				S. B. LeGrand, E. A. Khawam, D. Walsh, and N. I. Rivera Opioids, respiratory function, and dyspnea American Journal of Hospice and Palliative Medicine, January 1, 2003; 20(1): 57 - 61. [Abstract] [PDF]

				P. A. Kvale, M. Simoff, and U. B. S. Prakash Palliative Care Chest, January 1, 2003; 123 (2009): 284S - 311S. [Abstract] [Full Text] [PDF]

				S. P. Cohen and T. C. Dawson Nebulized Morphine as a Treatment for Dyspnea in a Child With Cystic Fibrosis Pediatrics, September 1, 2002; 110(3): e38 - 38. [Abstract] [Full Text] [PDF]

				P Good and B Stafford Inpatient palliative medicine is evidence based Palliative Medicine, September 1, 2001; 15(6): 493 - 498. [Abstract] [PDF]

				M Barnett Alternative opioids to morphine in palliative care: a review of current practice and evidence Postgrad. Med. J., June 1, 2001; 77(908): 371 - 378. [Full Text]

				M. Webb, L. E. Moody, and L. A. Mason Dyspnea assessment and management in hospice patients with pulmonary disorders American Journal of Hospice and Palliative Medicine, July 1, 2000; 17(4): 259 - 264. [Abstract] [PDF]

				L. Heyse-Moore, T. Beynon, and V. Ross Does spirometry predict dyspnoea in advanced cancer? Palliative Medicine, April 1, 2000; 14(3): 189 - 195. [Abstract] [PDF]

				R. E. Enck The role of nebulized morphine in managing dyspnea American Journal of Hospice and Palliative Medicine, January 1, 1999; 16(1): 373 - 374. [PDF]

				G. Zeppetella The palliation of dyspnea in terminal disease American Journal of Hospice and Palliative Medicine, November 1, 1998; 15(6): 322 - 330. [Abstract] [PDF]

				S. G. Mercadante When oral morphine fails in cancer pain: The role of the alternative routes American Journal of Hospice and Palliative Medicine, November 1, 1998; 15(6): 333 - 342. [PDF]